LYMPHOSEEK

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug LYMPHOSEEK contains one active pharmaceutical ingredient (API):

1 Technetium ⁹⁹ᵐTc tilmanocept UNII MDU8BQ474H - TILMANOCEPT

Technetium ⁹⁹ᵐTc tilmanocept is a receptor-targeted radiopharmaceutical that is designed to rapidly transit lymphatic vessels; it biotargets, accumulates, and is retained in primary, key predictive, draining lymph nodes (sentinel lymph nodes). Read about Technetium ⁹⁹ᵐTc tilmanocept

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LYMPHOSEEK Kit for radiopharmaceutical preparation	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IA09		V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IA Technetium (99mTc) compounds
Discover more medicines within V09IA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1669338, 1778463
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114955001
Country: FR	Base de données publique des médicaments	Identifier(s): 62978998
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 356395
Country: IT	Agenzia del Farmaco	Identifier(s): 043784014, 043784026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1023155, 1084581
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100332779